Reopening America

Supply Shortage of Pfizer’s Covid Pill Causes Uneven Rollout in U.S.

The rollout of the Pfizer’s Covid pills has faced shortages and criticism that state health departments are not prioritizing those at the highest risk of serious illness. The Biden administration has purchased 20 million courses of the treatment but has only been able to release 265,000 courses due to production delays. Benjamin Ryan, contributor to NBC News, joins us for a look inside the U.S. rollout. Learn more about your ad-choices at <a href="https://www.iheartpodcastnetwork.com">https://www.iheartpodcastnetwork.com</a>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.

We have shifted into a new phase in the coronavirus pandemic. We are social distancing, washing our hands, wearing face masks, and we are Reopening America. Oscar Ramirez from the Daily Dive Podcast updates you on any new information about the virus and vaccine development, but will focus on how cities, states, and industries affected by the shutdown are opening back up.